Log In
BCIQ
Print this Print this
 

CA19-9 radioimmunoassay

  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionCa 19-9 radioimmunoassay to detect exocrine pancreatic cancer
Molecular Target Not available
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today